The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S34-S37 , November 2004

AN OVERVIEW OF CHEMOTHERAPY TRIALS IN LOCALIZED AND RECURRENT NONMETASTATIC PROSTATE CANCER

  • WILLIAM K. OH

      Affiliations

    • Corresponding Author InformationCorrespondence: Dana-Farber Cancer Institute, 44 Binney St., Boston, Massachusetts 02115 (telephone: 617-632-3466; FAX: 617-632-2165)
    • Corresponding Author InformationFinancial interest and/or other relationship with Aventis and Bristol Myers

REFERENCES 

  1. Gilligan T , Kantoff PW . Chemotherapy for prostate cancer . Urology . 2002;60:94
  2. Petrylak DP . Chemotherapy for androgen-independent prostate cancer . Semin Urol Oncol . 2002;20:31
  3. Rosenbaum E , Carducci MA . Pharmacotherapy of hormone refractory prostate cancer: new developments and challenges . Expert Opin Pharmacother . 2003;4:875
  4. Oh WK . Secondary hormonal therapies in the treatment of prostate cancer . Urology . 2002;60:87
  5. Pound CR , Partin AW , Eisenberger MA , Chan DW , Pearson JD , Walsh PC . Natural history of progression after PSA elevation following radical prostatectomy . JAMA . 1999;281:1591
  6. D'Amico AV , Moul JW , Carroll PR , Sun L , Lubeck D , Chen MH . Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy . J Natl Cancer Inst . 2003;95:1376
  7. Taplin ME , Bubley GJ , Rajeshkumar B , Shuster T , Ko YJ , Morganstern DE . Docetaxel, estramustine, and short-term androgen withdrawal for patients with biochemical failure after definitive local therapy for prostate cancer . Semin Oncol . 2001;28:32
  8. Ajani J , Ettinger D , Kelsen DP , Hudis C , Kudelka A , Langer C , et al.   Radiation Therapy Oncology Group. Research Plan 2002–2006. Medical Oncology Committee . Int J Radiat Oncol Biol Phys . 2001;51:88
  9. Syed S , Petrylak DP , Thompson IM . Management of high-risk localized prostate cancer: the integration of local and systemic therapy approaches . Urol Oncol . 2003;21:235
  10. Skinner EC , Glode LM . High-risk localized prostate cancer: primary surgery and adjuvant therapy . Urol Oncol . 2003;21:219
  11. Wang J , Halford S , Rigg A , Roylance R , Lynch M , Waxman J . Adjuvant mitozantrone chemotherapy in advanced prostate cancer . BJU Int . 2000;86:675
  12. Narayan S , Smith DC , Sandler HM . Chemotherapy for localized, high-risk prostate cancer . Semin Radiat Oncol . 2003;13:152
  13. Oh WK . The evolving role of chemotherapy and other systemic therapies for managing localized prostate cancer . J Urol . 2003;170:S28
  14. Oh WK , George DJ , Kaufman DS , Moss K , Smith MR , Richie JP , et al.   Neoadjuvant docetaxel followed by radical prostatectomy in patients with high-risk localized prostate cancer: a preliminary report . Semin Oncol . 2001;28:40
  15. Dreicer R , Klein EA . Preliminary observations of single-agent docetaxel as neoadjuvant therapy for locally advanced prostate cancer . Semin Oncol . 2001;28:45
  16. Eastham JA , Kelly WK , Grossfeld GD , Small EJ , Cancer and Leukemia Group B  . Cancer and Leukemia Group B (CALGB) 90203: a randomized phase 3 study of radical prostatectomy alone versus estramustine and docetaxel before radical prostatectomy for patients with high-risk localized disease . Urology . 2003;62(suppl):55
  17. Pettaway CA , Pisters LL , Troncoso P , Slaton J , Finn L , Kamoi K , et al.   Neoadjuvant chemotherapy and hormonal therapy followed by radical prostatectomy: feasibility and preliminary results . J Clin Oncol . 2000;18:1050
  18. Clark PE , Peereboom DM , Dreicer R , Levin HS , Clark SB , Klein EA . Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer . Urology . 2001;57:281
  19. Hussain M , Smith DC , El-Rayes BF , Du W , Vaishampayan U , Fontana J , et al.   Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer . Urology . 2003;61:774

PII: S0022-5347(05)61305-5

doi: 10.1097/01.ju.0000141674.92253.fe

The Journal of Urology
Volume 172, Issue 5, Supplement , Pages S34-S37 , November 2004

Article Tools